Adalimumab-ryvk
NDC 51759-360, adalimumab-ryvk, kit, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 51759-360
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761299
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51759-360 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51759-360-02 | 51759036002 | 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-368-21) * .4 mL in 1 POUCH (65517-0002-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2d19a877-1f5a-4731-800a-dddadc424080
Use it
Look up 51759-360 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51759-360 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51759-360. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.